The chromatin scaffolding protein SMCHD1 (structural maintenance of chromosomes flexible hinge domain containing 1) was previously shown to have diverse roles in X-chromosome inactivation, imprinting and double-strand break repair, and mutations in SMCHD1 contribute to a type of muscular dystrophy. Now, development of the nose and eyes is added to its list of functions.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease
Nature Communications Open Access 25 September 2023
-
A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression
Scientific Reports Open Access 08 December 2021
-
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Orphanet Journal of Rare Diseases Open Access 12 March 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hong, S. et al. Hum. Mol. Genet. 25, 1912–1922 (2016).
Shaw, N.D. et al. Nat. Genet. 49, 238–248 (2017).
Gordon, C.T. et al. Nat. Genet. 49, 249–255 (2017).
Lemmers, R.J.L.F. et al. Nat. Genet. 44, 1370–1374 (2012).
Lemmers, R.J.L.F. et al. Hum. Mol. Genet. 24, 659–669 (2015).
Blewitt, M.E. et al. Nat. Genet. 40, 663–669 (2008).
Brideau, N.J. et al. Mol. Cell. Biol. 35, 4053–4068 (2015).
Chen, K. et al. Proc. Natl. Acad. Sci. USA 112, E3535–E3544 (2015).
Chen, K. et al. Biochem. J. 473, 1733–1744 (2016).
Ali, M.M. et al. Nature 440, 1013–1017 (2006).
Wolmarans, A., Lee, B., Spyracopoulos, L. & LaPointe, P. Sci. Rep. 6, 33179 (2016).
Hauk, G. & Berger, J.M. Curr. Opin. Struct. Biol. 36, 85–96 (2016).
Thiele, H., Musil, A., Nagel, F. & Majewski, F. Am. J. Med. Genet. 63, 310–313 (1996).
Vaughan, C.K., Piper, P.W., Pearl, L.H. & Prodromou, C. FEBS J. 276, 199–209 (2009).
Bagheri-Fam, S. et al. Hum. Mol. Genet. 24, 6699–6710 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Wilkie, A. Many faces of SMCHD1. Nat Genet 49, 176–178 (2017). https://doi.org/10.1038/ng.3776
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3776
This article is cited by
-
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease
Nature Communications (2023)
-
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Orphanet Journal of Rare Diseases (2021)
-
A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression
Scientific Reports (2021)
-
Rare variant of the epigenetic regulator SMCHD1 in a patient with pituitary hormone deficiency
Scientific Reports (2020)
-
A ubiquitin-like domain is required for stabilizing the N-terminal ATPase module of human SMCHD1
Communications Biology (2019)